Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 2,380.00
-20.00 (-0.83%)
At close: Apr 30, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 185.05 billion as of April 30, 2026. Its market cap has decreased by -39.64% in one year.
Market Cap
185.05B
Enterprise Value
268.41B
Revenue
19.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,380.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 185.05B, a decrease of -69.83%. That is a compound annual growth rate of -20.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 185.05B | -21.58% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 309.20B |
| Bio Solution | 295.98B |
| ABION | 236.52B |
| ViGenCell | 226.93B |
| Genome & Company | 221.57B |
| ISU Abxis | 201.00B |
| Ensol Biosciences | 186.26B |
| QuadMedicine | 160.86B |